
In September 2021, the U.S. Food and Drug Administration sent a warning letter to Genesis Medical Center in Irvine, California. The agency addressed it to Dr. Yamaha Zachariah Azar, the center’s managing partner. The FDA’s Center for Biologics Evaluation and Research staff examined the clinic’s websites, its Facebook page and a 2019 podcast appearance, and according to the letter, the center marketed a “stem cell therapy” derived from fat tissue, along with an exosome product.
The letter lists conditions mentioned in those materials, including autism, diabetes, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis and pulmonary fibrosis. It states the products reached patients by injection or nebulizer.
The agency wrote that the fat-derived product appeared to qualify as a human cell, tissue or cellular or tissue-based product. Based on its review, the FDA said the product did not appear to meet the criteria for lighter regulation and seemed intended for non-homologous use. Under that reading, the letter explains, the product would count as a drug and a biological product.
Federal law generally requires a valid biologics license to market such a product. A product still in development usually needs an investigational new drug application. The FDA added that exosomes intended for clinical use fall under the same premarket requirements.
The letter asked for a written response within 30 days. This article does not report on the clinic’s reply or on any later agency action. A warning letter states the FDA’s preliminary view. It does not amount to a court finding, and the agency noted its review was not all-inclusive.
Patients who paid for these treatments may want to look at their own experience. Useful questions include:
The Lyon Firm has filed stem cell clinic fraud class actions on behalf of plaintiffs nationwide. Our attorneys focus on consumer safety and deceptive medical marketing, and we understand how to build complex group cases against well-funded defendants.
If you or a loved one paid for stem cell or exosome treatment and want to understand your options, call (513) 381-2333 or contact us online for a free, confidential consultation.
Taking the first step doesn’t have to be complicated. In just a few minutes, you can share the basics of your case, and our team will guide you from there: